RU2008100342A - METHOD FOR TREATING ARTHROSO-ARTHRITIS - Google Patents

METHOD FOR TREATING ARTHROSO-ARTHRITIS

Info

Publication number
RU2008100342A
RU2008100342A RU2008100342/14A RU2008100342A RU2008100342A RU 2008100342 A RU2008100342 A RU 2008100342A RU 2008100342/14 A RU2008100342/14 A RU 2008100342/14A RU 2008100342 A RU2008100342 A RU 2008100342A RU 2008100342 A RU2008100342 A RU 2008100342A
Authority
RU
Russia
Prior art keywords
drugs
disease
arthritis
interstitial injection
arthroso
Prior art date
Application number
RU2008100342/14A
Other languages
Russian (ru)
Other versions
RU2417091C2 (en
Inventor
Надежда Александровна Гаряева (RU)
Надежда Александровна Гаряева
Игорь Геннадьевич Завгородний (RU)
Игорь Геннадьевич Завгородний
Original Assignee
Общество с ограниченной ответственностью "Международный центр клинической лимфологии" (RU)
Общество с ограниченной ответственностью "МЕЖДУНАРОДНЫЙ ЦЕНТР КЛИНИЧЕСКОЙ ЛИМФОЛОГИИ"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Общество с ограниченной ответственностью "Международный центр клинической лимфологии" (RU), Общество с ограниченной ответственностью "МЕЖДУНАРОДНЫЙ ЦЕНТР КЛИНИЧЕСКОЙ ЛИМФОЛОГИИ" filed Critical Общество с ограниченной ответственностью "Международный центр клинической лимфологии" (RU)
Priority to RU2008100342/15A priority Critical patent/RU2417091C2/en
Publication of RU2008100342A publication Critical patent/RU2008100342A/en
Application granted granted Critical
Publication of RU2417091C2 publication Critical patent/RU2417091C2/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

1. Способ лечения артрозо-артритов, в частности деструктивно-дистрофических заболеваний суставов (остеоартрозы различной локализации), остеохондроза и спондилеза, включающий введение иммуномодуляторов и хондропротекторов, отличающийся тем, что препараты, например, иммуномодулятор, хондропротектор вводят лимфотропно путем интерстициальной инъекции в скомпрометированную область в разовой дозе по схеме индивидуальной для пациента. ! 2. Способ по п.1, отличающийся тем, что препарат, комбинацию препаратов, последовательность введения и количество инъекций назначают в зависимости от этиопатогенеза заболевания и характера течения заболевания.1. A method for the treatment of arthrosis-arthritis, in particular destructive-dystrophic diseases of the joints (osteoarthritis of various localization), osteochondrosis and spondylosis, including the introduction of immunomodulators and chondroprotectors, characterized in that the drugs, for example, immunomodulator, chondroprotector are injected lymphotropically by interstitial injection into the interstitial injection in a single dose according to the scheme individual for the patient. ! 2. The method according to claim 1, characterized in that the drug, the combination of drugs, the sequence of administration and the number of injections are prescribed depending on the etiopathogenesis of the disease and the nature of the course of the disease.

Claims (2)

1. Способ лечения артрозо-артритов, в частности деструктивно-дистрофических заболеваний суставов (остеоартрозы различной локализации), остеохондроза и спондилеза, включающий введение иммуномодуляторов и хондропротекторов, отличающийся тем, что препараты, например, иммуномодулятор, хондропротектор вводят лимфотропно путем интерстициальной инъекции в скомпрометированную область в разовой дозе по схеме индивидуальной для пациента.1. A method for the treatment of arthrosis-arthritis, in particular destructive-dystrophic diseases of the joints (osteoarthritis of various localization), osteochondrosis and spondylosis, including the introduction of immunomodulators and chondroprotectors, characterized in that the drugs, for example, immunomodulator, chondroprotector are injected lymphotropically by interstitial injection into the interstitial injection in a single dose according to the scheme individual for the patient. 2. Способ по п.1, отличающийся тем, что препарат, комбинацию препаратов, последовательность введения и количество инъекций назначают в зависимости от этиопатогенеза заболевания и характера течения заболевания. 2. The method according to claim 1, characterized in that the drug, the combination of drugs, the sequence of administration and the number of injections are prescribed depending on the etiopathogenesis of the disease and the nature of the course of the disease.
RU2008100342/15A 2008-01-09 2008-01-09 Method of treating osteoarthritis RU2417091C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2008100342/15A RU2417091C2 (en) 2008-01-09 2008-01-09 Method of treating osteoarthritis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2008100342/15A RU2417091C2 (en) 2008-01-09 2008-01-09 Method of treating osteoarthritis

Publications (2)

Publication Number Publication Date
RU2008100342A true RU2008100342A (en) 2009-07-20
RU2417091C2 RU2417091C2 (en) 2011-04-27

Family

ID=41046572

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2008100342/15A RU2417091C2 (en) 2008-01-09 2008-01-09 Method of treating osteoarthritis

Country Status (1)

Country Link
RU (1) RU2417091C2 (en)

Also Published As

Publication number Publication date
RU2417091C2 (en) 2011-04-27

Similar Documents

Publication Publication Date Title
EA201101507A1 (en) METHODS OF TREATMENT OF SOLID TUMORS
CY1113253T1 (en) Dosage regimen for therapeutic treatment of a traumatic brain injury with progesterone
WO2008039898A3 (en) Methods for the treatment of a traumatic central nervous system injury
NZ625391A (en) Human anti-ngf neutralizing antibodies as selective ngf pathway inhibitors
MX2013004406A (en) Treating diabetes melitus using insulin injections administered with varying injection intervals.
RU2020134307A (en) MELFLUFENE DOSING REGIMES FOR CANCER
RU2013123646A (en) COMBINED COMPOSITION
RU2008100342A (en) METHOD FOR TREATING ARTHROSO-ARTHRITIS
RU2019141383A (en) METHODS FOR TREATMENT OF CERVICAL DYSTONIA
MX2019008076A (en) Therapeutic regimen for the treatment of fabry using stabilized alpha-galactosidase.
MY174442A (en) Treating critically ill patients with intravenous ibuprofen
RU2014154396A (en) LIQUID MEDICINAL CONTAINING CARBON OXIDE DISSOLVED IN IT AND THE THERAPEUTIC METHOD OF USE
RU2501563C1 (en) Method of treating localised forms of psoriasis
EA200802421A1 (en) METHOD OF TREATMENT ENDOMETRIOSIS
RU2233664C2 (en) Method for treatment of lichen ruber planus
RU2004111044A (en) DRUG FOR TREATMENT OF A HEMORRHAGIC STROKE AND METHOD FOR TREATING A HEMORRHAGIC STROKE
RU2005111607A (en) METHOD FOR TREATING SCARS
EA201590323A1 (en) METHOD OF INTRODUCTION OF ACTIVE SUBSTANCES IN THE HEAD BRAIN
RU2568889C1 (en) Method of treating pylorospasm following pylorus-preserving pancreatoduodenectomy
Munkhtsatsral et al. PHARMACOLOGICAL TREATMENT OF NON-ACTION IN VIVO ENVIRONMENT AS RESEARCH
RU2012155369A (en) METHOD FOR TREATING ULCER PILORODUODENAL STENOSIS
RU2011102742A (en) METHOD FOR TREATING INVOLUTIONAL EYE DISEASES
Lu Acute infusion reaction, rash and bellyache: 2 case reports
UA42030U (en) Method for treatment and prevention of hypodermathosis in cattle
RU2006134154A (en) METHOD FOR THERAPY OF INDIVIDUAL DISORDERS IN THE BLOOD SYSTEM UNDER EXPERIMENTAL NEUROTIC INFLUENCES

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20160110

NF4A Reinstatement of patent

Effective date: 20170421

MM4A The patent is invalid due to non-payment of fees

Effective date: 20210110